CHILDRESS CAPITAL ADVISORS, LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1849561
HOUSTON, TX
Position in REGN
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$326,111
-$111,975 QoQ
Shares Held
523
-7.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#920
of 1,322 holders
Holding Since
Dec 2020
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHILDRESS CAPITAL ADVISORS, LLC holds $906,617 across 3 Biotechnology names. REGN ranks #1 (36.0% of the industry book) .
All Filings in REGN
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $326,111 | 523 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $438,086 | 567 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $315,694 | 409 | Shares | Sole | 2026-01-26 | |
| 2024-09-30 | $284,886 | 271 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $285,880 | 272 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $268,534 | 279 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $342,533 | 390 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $297,911 | 362 | Shares | Sole | 2023-11-06 | |
| 2022-12-31 | $239,534 | 332 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $225,949 | 328 | Shares | Sole | 2022-11-04 | |
| 2020-12-31 | $30,435 | 63 | Shares | Sole | 2021-03-09 | |
| No filing history on record for this holder in this stock. | ||||||